Report cover image

Cell Dissociation Market by Product (Enzymatic Dissociation Products, Instruments & Accessories, Non-Enzymatic Dissociation Products), Type (Cell Detachment, Tissue Dissociation), Tissue, End-User - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 185 Pages
SKU # IRE18436962

Description

Cell Dissociation Market by Product (Enzymatic Dissociation Products, Instruments & Accessories, Non-Enzymatic Dissociation Products), Type (Cell Detachment, Tissue Dissociation), Tissue, End-User - Global Forecast 2024-2030


The Cell Dissociation Market size was estimated at USD 759.32 million in 2023 and expected to reach USD 878.60 million in 2024, at a CAGR 16.91% to reach USD 2,267.64 million by 2030.Cell dissociation, also known as cell disruption or fractionation, consists of a process by which cells is broken down into smaller parts for further study or analysis. The growth of the cell dissociation market is primarily driven by the prevalence of cell-based research initiated by many pharmaceutical and biotechnology companies. Cell dissociation is vital in biopharmaceutical research as it is directly involved in drug development and pathophysiology elucidation. The biopharmaceutical industry is a fast-growing area of the pharmaceutical industry with major implications for healthcare. As a result of the high efficacy and safety of these treatments, opportunities in biopharmaceuticals have grown significantly during the last decade. However, isolation and purification of cell organelles integrate expensive products, and automated or semi-automated benchtop instruments are more expensive than traditional methods, which may limit product adoption, further restraining market growth. Nevertheless, increasing funding for stem cell research by government bodies and companies is expected to offer new growth opportunities for the industry.Regional InsightsThe market is growing due to increased spending by biopharmaceutical companies on R&D operations across North America, Europe, and Asia-Pacific regions. North America has dominated the market for the last few years, attributed to the rise in investment initiatives by the U.S. government, increasing chronic disease incidences, such as cancer, along with high-quality infrastructure for clinical & laboratory research in the U.S. and Canada. The Asia Pacific region is expected to grow rapidly during the forecast period due to the rising demand for novel therapeutics in the countries such as China, Japan, and India. Furthermore, increasing R&D investments and rapid infrastructural development are key factors fueling the market growth in China and India. Asia-Pacific’s pharmaceutical market has remained highly competitive and fragmented, with numerous small manufacturers competing for market shares. From an economic and policy standpoint, government support is expected to drive innovation in life sciences research and the growth of the pharmaceutical and biopharmaceutical sector. In Europe, several companies from the U.K. and Germany are investing heavily to develop a treatment for various chronic diseases such as heart diseases and cancer, which is expected to contribute toward market growth across Europe.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Dissociation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Dissociation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Dissociation Market, highlighting leading vendors and their innovative profiles. These include Abeomics Inc., AcceGen, ACROBiosystems Group, ALSTEM, AMS Biotechnology, Becton, Dickinson and Company, Bio-Techne Corporation, Biogenuix Medsystems Pvt. Ltd., Capricorn Scientific, Captivate Bio, LLC, Cell Signaling Technology, Inc., Cellseco Ltd., Cellsystems Gmbh, Celprogen Corporation, Central Drug House. (P) Ltd., Corning Inc., Creative Bioarray, Cytori Therapeutics Inc., Diagnocine, F. Hoffmann-La Roche Ltd., FlowMetric, Inc., Gemini BioProducts LLC, Genaxxon bioscience GmbH, Genlantis Inc., Genomics, Inc., HiMedia Laboratories Private Limited, Innovative Cell Technologies, Inc., Krackeler Scientific, Inc., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, MP Biomedicals, LLC, Nacalai Tesque, Inc., Neuromics, Nordmark Pharma GmbH, PAN-Biotech GmbH, PELOBIOTECH GmbH, PromoCell GmbH, Protein Ark Ltd. by CalibreScientific, REPROCELL Inc., RWD Life Science Co., Ltd., Sartorius AG, ScienCell Research Laboratories, Inc., Singleron Biotechnologies GmbH, STEMCELL Group, Stemmera Inc., Tebubio, Thermo Fisher Scientific Inc., VitaCyte, LLC, VWR International, LLC, and Worthington Biochemical Corporation.

Market Segmentation & Coverage


This research report categorizes the Cell Dissociation Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Enzymatic Dissociation Products
Collagenase

DNase

Elastase

Hyaluronidase

Papain

Trypsin
Instruments & Accessories
Non-Enzymatic Dissociation Products
Type
Cell Detachment
Tissue Dissociation
Tissue
Connective Tissues
Epithelial Tissues
Skeletal & Muscles Tissues
End-User
Pharmaceutical & Biotechnology Companies
Research & Academics
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Dissociation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Dissociation Market?
3. What are the technology trends and regulatory frameworks in the Cell Dissociation Market?
4. What is the market share of the leading vendors in the Cell Dissociation Market?
5. Which modes and strategic moves are suitable for entering the Cell Dissociation Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

185 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cell Dissociation Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cell based research activities across pharmaceutical and biopharmaceutical companies
5.1.1.2. Rising incidence and prevalence of chronic and infectious diseases
5.1.1.3. Availability of government funding for stem-cell research activities
5.1.2. Restraints
5.1.2.1. High cost of tissue and cell based procedures
5.1.3. Opportunities
5.1.3.1. Ongoing introduction of advanced cell dissociation products
5.1.3.2. Rising regulatory approvals for the cell dissociation developments
5.1.4. Challenges
5.1.4.1. Limited infrastructure for the cell-based research in underdeveloped countries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cell Dissociation Market, by Product
6.1. Introduction
6.2. Enzymatic Dissociation Products
6.3.1. Collagenase
6.3.2. DNase
6.3.3. Elastase
6.3.4. Hyaluronidase
6.3.5. Papain
6.3.6. Trypsin
6.3. Instruments & Accessories
6.4. Non-Enzymatic Dissociation Products
7. Cell Dissociation Market, by Type
7.1. Introduction
7.2. Cell Detachment
7.3. Tissue Dissociation
8. Cell Dissociation Market, by Tissue
8.1. Introduction
8.2. Connective Tissues
8.3. Epithelial Tissues
8.4. Skeletal & Muscles Tissues
9. Cell Dissociation Market, by End-User
9.1. Introduction
9.2. Pharmaceutical & Biotechnology Companies
9.3. Research & Academics
10. Americas Cell Dissociation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Dissociation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cell Dissociation Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Agilent Announces Acquisition of Company Behind Electron Capture Dissociation Technology
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia
13.3.2.2. Applied Cells Enters into a Supply Agreement with STEMCELL Technologies on Reagent Kits for Use in a Next-Generation Solution for Cell Separation
13.3.3. New Product Launch & Enhancement
13.3.3.1. LevitasBio Unveils LeviPrep and LeviSelect Product Lines
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abeomics Inc.
14.1.2. AcceGen
14.1.3. ACROBiosystems Group
14.1.4. ALSTEM
14.1.5. AMS Biotechnology
14.1.6. Becton, Dickinson and Company
14.1.7. Bio-Techne Corporation
14.1.8. Biogenuix Medsystems Pvt. Ltd.
14.1.9. Capricorn Scientific
14.1.10. Captivate Bio, LLC
14.1.11. Cell Signaling Technology, Inc.
14.1.12. Cellseco Ltd.
14.1.13. Cellsystems Gmbh
14.1.14. Celprogen Corporation
14.1.15. Central Drug House. (P) Ltd.
14.1.16. Corning Inc.
14.1.17. Creative Bioarray
14.1.18. Cytori Therapeutics Inc.
14.1.19. Diagnocine
14.1.20. F. Hoffmann-La Roche Ltd.
14.1.21. FlowMetric, Inc.
14.1.22. Gemini BioProducts LLC
14.1.23. Genaxxon bioscience GmbH
14.1.24. Genlantis Inc.
14.1.25. Genomics, Inc.
14.1.26. HiMedia Laboratories Private Limited
14.1.27. Innovative Cell Technologies, Inc.
14.1.28. Krackeler Scientific, Inc.
14.1.29. Merck KGaA
14.1.30. Miltenyi Biotec B.V. & Co. KG
14.1.31. MP Biomedicals, LLC
14.1.32. Nacalai Tesque, Inc.
14.1.33. Neuromics
14.1.34. Nordmark Pharma GmbH
14.1.35. PAN-Biotech GmbH
14.1.36. PELOBIOTECH GmbH
14.1.37. PromoCell GmbH
14.1.38. Protein Ark Ltd. by CalibreScientific
14.1.39. REPROCELL Inc.
14.1.40. RWD Life Science Co., Ltd.
14.1.41. Sartorius AG
14.1.42. ScienCell Research Laboratories, Inc.
14.1.43. Singleron Biotechnologies GmbH
14.1.44. STEMCELL Group
14.1.45. Stemmera Inc.
14.1.46. Tebubio
14.1.47. Thermo Fisher Scientific Inc.
14.1.48. VitaCyte, LLC
14.1.49. VWR International, LLC
14.1.50. Worthington Biochemical Corporation
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. CELL DISSOCIATION MARKET RESEARCH PROCESS
FIGURE 2. CELL DISSOCIATION MARKET SIZE, 2023 VS 2030
FIGURE 3. CELL DISSOCIATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CELL DISSOCIATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CELL DISSOCIATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CELL DISSOCIATION MARKET DYNAMICS
FIGURE 7. CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CELL DISSOCIATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. CELL DISSOCIATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2023 VS 2030 (%)
FIGURE 12. CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CELL DISSOCIATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. CELL DISSOCIATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CELL DISSOCIATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. CELL DISSOCIATION MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us